Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma

被引:0
作者
J. Ni
T. Zhu
L. Zhao
F. Che
Y. Chen
H. Shou
A. Yu
机构
[1] Zhejiang Cancer Hospital,Department of Gynecologic Oncology
来源
Clinical and Translational Oncology | 2015年 / 17卷
关键词
Endometrial adenocarcinoma; Metabolic syndrome; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:835 / 839
页数:4
相关论文
共 107 条
[1]  
Furberg AS(2003)Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort Int J Cancer 104 669-676
[2]  
Thune I(2010)Role of progesterone in endometrial cancer Semin Reprod Med 28 81-90
[3]  
Kim JJ(2007)Body size in relation to cancer of the uterine corpus in 1 million Norwegian women Int J Cancer 120 378-383
[4]  
Chapman-Davis E(2013)Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31 2607-2618
[5]  
Bjørge T(2011)Case–control study of the metabolic syndrome and metabolic risk factors for endometrial cancer Cancer Epidemiol Biomarkers Prev 20 2384-2395
[6]  
Engeland A(2011)Metabolic syndrome and endometrial cancer risk Ann Oncol 22 884-889
[7]  
Tretli S(2012)Metabolic syndrome and risk of cancer: a systematic review and meta-analysis Diabetes Care 35 2402-2411
[8]  
Weiderpass E(2006)Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation Diabet Med 23 469-480
[9]  
Setiawan VW(2000)Theories of endometrial carcinogenesis: a multidisciplinary approach Mod Pathol 13 295-308
[10]  
Yang HP(1983)Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 10-17